The acute kidney injury therapeutics market is expanding as healthcare providers focus on earlier detection, improved critical-care management, and better support for patients at risk of sudden kidney-function decline. The market was valued at USD 2.14 billion in 2024 and is projected to reach USD 3.4 billion by 2032, growing at a CAGR of 5.97%. 1185 Acute kidney injury, or AKI, is a sudden...